IMSC News Alert Implant Sciences Cp (IMSC) 0.9600 12/25/2014

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Implant Sciences Cp (IMSC) 0.9600 $IMSC

Implant Sciences' QS-B220 Receives Regulatory Approval for China Airports and Civil Aviation Industry
PR Newswire - Tue Dec 23, 9:48AM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today its QS-B220 desktop explosives and drugs trace detector has received approval from the Civil Aviation Administration of China (CAAC).

IMSC SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Implant Sciences Corp.
PR Newswire - Tue Dec 09, 10:38AM CST
Levi & Korsinsky, LLP is investigating Implant Sciences Corp. (OTC: IMSC) in connection with possible claims of breaches of fiduciary duty.

Implant Sciences Receives Notification of Protest to Recent Award under Solicitation HTHS04-14-R-CT2050
PR Newswire - Wed Nov 26, 2:53PM CST
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today that it has received notification that a bid protest has been filed with the Government Accountability Office (GAO) regarding the company's recent ETD award under Solicitation HTHS04-14-R-CT2050.

Implant Sciences' QS-B220 Named "Best Explosives Detection Solution" for the 2nd Consecutive Year
PR Newswire - Wed Nov 26, 6:00AM CST
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, announced today its QS-B220 desktop explosives and drugs trace detector has won the 2014 GSN Homeland Security Award for "Best Explosives Detection Solution". This marks the second year in a row that the QS-B220 has been given this award.

NATO Member Military Purchases 18 QS-H150 Explosives Trace Detectors from Implant Sciences
PR Newswire - Mon Nov 24, 6:00AM CST
Implant Sciences Corporation (OTCQB: IMSC), a leading manufacturer of explosives trace detection (ETD) and drugs trace detection solutions for homeland security applications, today announced the Company has won a competitive contract for 18 QS-H150s to be shipped to a county in the EMEA region (Europe, the Middle East and Africa). The country which made the purchase is a North Atlantic Treaty Alliance (NATO) member nation and will use Implant Sciences' handheld explosive trace detectors in military applications.

Implant Sciences to Conduct Press Conference & Demonstration of its QS-B220 Explosives Trace Detector on Monday, November 17 at 10:30am ET
PR Newswire - Fri Nov 14, 3:19PM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today it will conduct a press conference on Monday, November 17, 2014 at 10:30 am ET at the Marriott Marquis Times Square, New York City. Implant Sciences will discuss significant recent Company events and will conduct live demonstrations of the QS-B220, which is the first non-radioactive explosives trace detector (ETD) to be approved for baggage and passenger screening by the TSA.

Implant Sciences Reports First Quarter Fiscal 2015 Financial Results
PR Newswire - Fri Nov 14, 6:00AM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, today announced financial results for the three months ended September 30, 2014.

Implant Sciences Receives Order from TSA for 1,170 Explosive Trace Detectors
PR Newswire - Thu Nov 13, 11:11AM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that the U.S. Transportation Security Administration (TSA) has placed an initial order for 1,170 QS-B220 Desktop Explosive Trace Detectors and ancillary supplies. The systems will be deployed at multiple airports across the country.

Implant Sciences To Announce First Quarter Fiscal 2015 Financial Results On November 14, 2014
PR Newswire - Wed Nov 12, 3:15PM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, will host a webcast and conference call on Friday, November 14, 2014 at 11:00 a.m. to discuss the financial results for the quarter ended September 30, 2014.

Implant Sciences signs TSA IDIQ Contract for up to $162 million dollars for explosive trace detection systems
PR Newswire - Tue Nov 11, 8:00AM CST
Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today it has entered into an Indefinite Delivery / Indefinite Quantity (IDIQ) contract with the United States Transportation Security Administration (TSA) for its QS-B220 desktop explosives trace detectors, which recently received TSA qualification for airport checkpoint passenger and baggage screening. The IDIQ, a necessary prerequisite for competing for TSA's annual trace detection procurements, establishes contract terms under which the TSA could purchase up to $162 million of equipment and services.

Implant Sciences to Exhibit at Airport Council International's 2014 Airport Exchange in Paris on November 3 - 5, 2014
PR Newswire - Mon Nov 03, 6:00AM CST
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today it will exhibit at booth C9 at Airport Council International's ACI Europe & ACI Asia-Pacific Airport Exchange 2014. ACI Airport Exchange is an important event in the air transport industry, with an expected attendance of more than 2,500 aviation business executives from Europe, Asia Pacific and around the world.

Implant Sciences to Sponsor Session on the Future of Aviation Security at AVSEC World 2014 Conference in Washington D.C.
PR Newswire - Mon Oct 27, 6:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced its participation in the 23rd Annual AVSEC World 2014 Conference on October 27 - 29, 2014 in Washington D.C. The Company will exhibit its QS-B220 explosives trace detector (ETD) at booth #17. The QS-B220 is the only ETD in the world that has been placed on the U.S. Transportation Security Administration's (TSA) Qualified Product List and passed the Common Evaluation Process (CEP) defined by the 44 member nation European Civil Aviation Conference (ECAC).

Implant Sciences Ships over $600,000 in Explosives Trace Detectors to Customers in Europe, the Middle East, and Africa
PR Newswire - Thu Oct 23, 11:00AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today stated that it has shipped over $600,000 in previously unannounced orders of QS-H150 and QS-B220s to multiple customers in Europe, the Middle East, and Africa. Customers for the handheld and desktop explosives trace detectors include airports, cargo companies, hotels, and petroleum industry facilities.

Implant Sciences Selected to Receive up to $2,000,000 from the Department of Homeland Security to Develop Next-Generation Explosives Trace Detection Systems
PR Newswire - Thu Oct 16, 11:12AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that the U.S. Department of Homeland Security has selected Implant Sciences' proposal to develop next generation explosives trace detection (ETD) screening systems for funding. The project, pending successful negotiations, is worth up to approximately $2 million to the Company.

Implant Sciences' QS-B220 Passes European Civil Aviation Conference Common Evaluation Process
PR Newswire - Mon Oct 06, 10:39AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, announced today that the QS-B220 has successfully passed the European Civil Aviation Conference's (ECAC) Common Evaluation Process of Security Equipment (CEP) for airport checkpoint screening of passengers and baggage. The QS-B220 is the first Explosives Trace Detector (ETD) to pass ECAC's stringent laboratory testing protocol. The CEP was established to provide standards for security equipment performance across ECAC's 44 member nations. The QS-B220 was also recently added to the Transportation Security Administration's (TSA) Qualified Products List (QPL) in the U.S.

Implant Sciences Responds to Levi & Korsinsky, LLP Press Release/Solicitation
PR Newswire - Wed Oct 01, 7:00AM CDT
In response to a press release/general solicitation by the class action law firm, Levi & Korsinsky, LLP, Glenn D. Bolduc, CEO of Implant Sciences Corporation (OTCQB:IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, said today: "Levi & Korsinsky's press release/solicitation is identical to the press release it issued on August 8. The new release contains no new information and identifies no grounds whatsoever for an investigation of Implant Sciences or its board of directors. The firm has never contacted us directly, and we are not aware of any basis for an investigation. We do not believe this law firm's actions will benefit our shareholders, and we continue to encourage our shareholders and other interested parties to draw their own conclusions about the motivation behind this law firm's actions."

IMPLANT SCIENCES CORP. SHAREHOLDER ALERT: The Law Firm of Levi & Korsinsky, LLP Launches an Investigation into Possible Breaches of Fiduciary Duty by the Board of Directors of Implant Sciences Corp.
Business Wire - Tue Sep 30, 3:02PM CDT
Levi & Korsinsky, LLP is investigating Implant Sciences Corp. (OTC:IMSC) in connection with possible claims of breaches of fiduciary duty.

Implant Sciences Reports Fourth Quarter and Fiscal 2014 Financial Results
PR Newswire - Mon Sep 29, 3:10PM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, today announced financial results for the three months and fiscal year ended June 30, 2014.

Implant Sciences to Announce Fourth Quarter and Fiscal 2014 Financial Results on September 29, 2014
PR Newswire - Thu Sep 25, 3:24PM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for the homeland security market and related industries, will host a webcast and conference call on Monday, September 29, 2014 at 4:15 p.m. to discuss the financial results for the quarter and fiscal year ended June 30, 2014.

Implant Sciences to Present at NIBA Conference in New York City on September 16, 2014
PR Newswire - Mon Sep 15, 9:35AM CDT
Implant Sciences Corporation (OTCQB: IMSC), a high technology supplier of systems and sensors for homeland security and defense markets, today announced its CEO Glenn D. Bolduc is scheduled to present at the National Investment Banking Association's (NIBA) 132nd Investment Conference on Tuesday, September 16, 2014 at 11:55 am ET. The conference takes place in New York City on September 15th through 17th at the Roosevelt Hotel.




Scroll down for more posts ▼

Top 10 Most Recent News Articles

D-Wave Investors Face a December 15 Lead Plaintiff Clock

Updated Category News Views 98

August Put the Story Under a Harsh Light Two ugly August trading sessions are doing a lot of work in the case now confronting D-Wave Quantum. The company sits in a field that attracts big dreams, big headlines, and, frankly, plenty of investor imagination. But imagination does not cushion a portfolio when expectations crack. The lawsuits concern people who bought or...

Continue Reading
Debevoise Builds Its PE M&A Bench With McBain Hire

Updated Category News Views 92

Law-firm hiring rarely makes a market blink, yet this one carries a decent whiff of where the deal work is gathering. Debevoise & Plimpton has brought Jenna McBain into its New York Mergers & Acquisitions Group as a partner, putting another experienced private-equity adviser on a platform the firm plainly intends to keep enlarging. McBain arrives from Weil, Gotshal &...

Continue Reading
Domino's Probe Puts Franchise Disclosure Under Lens

Updated Category News Views 110

A franchisee's shuttered stores can turn cheerful unit-growth talk into a nasty accounting of credibility, and that is the uncomfortable territory Domino's now occupies. Kahn Swick & Foti has opened an investigation into whether Domino's officers and directors breached fiduciary duties or violated state or federal law. That is not a finding of misconduct. It is a legal...

Continue Reading
CASEKOO's Montana Story Makes Brand Purpose Personal

Updated Category News Views 50

A blurry Montana kitchen, not a glossy product render, is doing the heavy lifting for CASEKOO this Thanksgiving. That is either a smart bit of brand discipline or a sentimental detour, depending on whether the company can make people feel something without losing sight of why they bought a phone case in the first place. Warmth Takes the Place of Hardware CASEKOO's new...

Continue Reading
Chord's $550 Million Exit Tightens Its Basin Focus

Updated Category News Views 69

One map pin just disappeared from Chord Energy’s corporate wall, and that matters more than the usual deal-closing confetti. Chord has completed the sale of its entire non-operated Marcellus position to POSCO International for $550 million in gross consideration. For shareholders in NASDAQ:CHRD, this is not a flashy new drilling story. It is a cleanup job, and sometimes...

Continue Reading
Tampa General's Food Bet Earns a 2026 Innovation Award

Updated Category News Views 78

Hospital meals have long been the punchline nobody bothered to fix, which is why Tampa General Hospital's latest recognition deserves a closer look. The not-for-profit academic health system was named the 2026 Inno Pick by the Tampa Bay Business Journal for its Food as Medicine initiative, its fifth straight year landing among the publication's Inno Award honorees. Awards...

Continue Reading
Alibaba Lawsuit Deadline Puts Disclosure Risk in Focus

Updated Category News Views 169

A calendar deadline is doing more work than any earnings headline for Alibaba shareholders this week. A securities class action notice says investors who bought or acquired Alibaba Group Holding Limited securities between May 23, 2024 and November 11, 2026 may seek appointment as lead plaintiff by January 19, 2027. That is a procedural milestone, not a verdict, and...

Continue Reading
Pinnacol’s Community Work Earns Denver Chamber Recognition

Updated Category News Views 67

A workers’ comp insurer usually becomes visible on somebody’s worst day; Pinnacol Assurance is being recognized for the work it keeps doing around those days. The Denver Metro Chamber of Commerce has given the Colorado-based, member-owned carrier its 2026 Business Impact Award for Corporate Social Responsibility. Awards can be cheap applause, frankly. This one...

Continue Reading
SEIA's Young Advisors Put Succession Plans to the Test

Updated Category News Views 67

A $166 million average book is not a cute training-program statistic. It says SEIA’s advisors aged 30 to 39 are already carrying serious client responsibility, and that matters because the registered investment advisory business is headed into a succession crunch nobody can solve with a glossy recruiting brochure. You Cannot Hand Off Trust Like a Spare Key Clients may...

Continue Reading
Webster First Takes Aim at the Youth Money Literacy Gap

Updated Category News Views 86

Money mistakes get expensive long before anyone calls them mistakes. That is the uncomfortable point beneath Webster First Federal Credit Union CEO John Thomasian's November 20, 2026 discussion of financial literacy: plenty of young adults are entering the real financial world with a card, a loan offer, and a phone full of banking apps, but no sturdy framework for using...

Continue Reading

Top 5 Most Recently Viewed Articles

Ross Gerber Expresses Optimism for Meta's Phone-Free Future

Updated Category News Views 242

Ross Gerber Praises Meta's Smart Glasses Technology Over the weekend, investor Ross Gerber expressed his admiration for Meta Platforms, Inc. (NASDAQ: META) smart glasses, affirming their potential to transform our relationship with technology. Gerber noted that this innovative eyewear gives him hope for a day when he might no longer rely on his smartphone. Smart Glasses:...

Continue Reading
Organ-on-a-Chip Market Insights and Future Projections

Updated Category News Views 118

Understanding the Organ-on-a-Chip Market Growth As technology evolves, the quest for more accurate and human-relevant drug testing models takes center stage. The Organ-on-a-Chip (OOC) market has emerged as a revolutionary force, previously valued at around USD 117.67 million, and now set to skyrocket to approximately USD 1.64 billion by 2032. This innovative approach is...

Continue Reading
Discovering Blue Light Cystoscopy Benefits in Bladder Cancer

Updated Category News Views 240

New Insights on Blue Light Cystoscopy and Bladder Cancer Photocure ASA, known as the Bladder Cancer Company, has made significant advancements in bladder cancer management with the recent study titled "Oncologic Outcomes of Blue Light Cystoscopy in an Equal Access Setting: Results of the BRAVO Study." This research published in JU Open Plus provides compelling evidence...

Continue Reading
BioCryst's Bold Move: Astria Therapeutics Acquisition Insights

Updated Category News Views 211

BioCryst Enhances HAE Portfolio with Astria Acquisition BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has made a significant announcement regarding its acquisition of Astria Therapeutics, Inc. (NASDAQ: ATXS). This strategic move will strengthen BioCryst's position in the hereditary angioedema (HAE) market, as they plan to integrate Astria's promising therapies and...

Continue Reading
Milestone Scientific Reaches New Height with Strong Growth

Updated Category News Views 361

Milestone Scientific Achieves 52-Week High Milestone Scientific Inc. (NYSE: MLSS) has reached a significant milestone with its stock trading at $1.28, marking a 52-week high. This impressive achievement highlights the company's robust annual growth and increased investor confidence. As a result, the current market capitalization has reached approximately $97.37 million,...

Continue Reading